BioAge Labs, Inc. (BIOA) vs Lifecore Biomedical, Inc. (LFCR)
- BioAge Labs, Inc. BIOA 4.82 −9.91%
- Lifecore Biomedical, Inc. LFCR 6.38 −0.93%
BioAge Labs, Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. and Lifecore Biomedical, Inc. are of similar size ($245.6M and $244.1M). Lifecore Biomedical, Inc. has the higher net margin (−37.5% vs −912.3%) and the higher return on invested capital (−2.80% vs −118.3%). Across the 15 metrics below, Lifecore Biomedical, Inc. leads on 10 and BioAge Labs, Inc. on 5.
Valuation
Profitability
| Metric | BIOA | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 26.86% | 53.94% |
| Operating margin | (1,026.28%) | (6.89%) | 0.00% |
| Net margin | (912.25%) | (37.54%) | 0.00% |
| Free cash flow margin | (2,345.11%) | (4.24%) | 0.00% |
| Return on equity | (28.21%) | 201.15% | (0.40%) |
| Return on assets | (26.27%) | (19.32%) | (3.32%) |
| Return on invested capital | (118.25%) | (2.80%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack